GlaxoSmithKline

GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

GlaxoSmithKline RSS Channel

List of articles in category GlaxoSmithKline
Title	Published Date
GSK joins with research councils in UK and South Africa to tackle non-communicable diseases	10 September 2014
Ebola vaccine trials fast-tracked by international consortium	29 August 2014
Where do you start when developing a new medicine?	27 March 2014
GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %	10 March 2014
Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation	14 January 2014
GSK adds detailed clinical trial data to multi-sponsor request system	06 January 2014
GSK responds to FDA decision on Avandia (rosiglitazone)	27 November 2013
H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure	25 November 2013
Five inspirational organisations from Malawi, Bangladesh, Mali, Kenya, and Colombia recognised by GSK and Save the Children	18 November 2013
GSK names inaugural winners in unique competition for academic drug hunters	10 November 2013

Business & Industry

GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
Merck initiates first clinical trial of TLR7 and 8 inhibitor as a potential treatment for severe symptoms of COVID-19 infection
Novartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US
Pfizer and BioNTech announce early positive data from an ongoing Phase 1/2 study of mRNA-based vaccine candidate against SARS-CoV-2
Lilly begins world's first study of a potential COVID-19 antibody treatment in humans

Research & Development

Conferences & Events

Regulatory Affairs